Level B· Emerging clinical evidence with positive signalsRandomized Controlled TrialPubMed

Immediate SVF-Gel Injection Reduced Incision Scar Formation: A Prospective, Double-Blind, Randomized, Self-control Trial.

Rong X., Tang J., Yang J., Wang K., Dang J., Yu Z.

Randomized Controlled Trial on Chronic Wound, Scar, published in Aesthetic Plast Surg (2024) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Randomized Controlled Trial
Journal
Aesthetic Plast Surg (2024)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
38831065
DOI
10.1007/s00266-024-04126-7
Citations
7

Abstract (original English)

Background Skin incision scars are cosmetically displeasing; the effects of current treatments are limited, and new methods to reduce scar formation need to be found. Objective We sought to determine whether immediate postoperative injection of stromal vascular fraction gel (SVF-gel) could reduce scar formation at skin incision sites. Methods A prospective, randomized, double-blind, self-controlled trial was conducted in patients who underwent breast reduction. SVF-gel was intradermally injected into the surgical incision on one randomly selected side, with the other side receiving saline as a control. At the 6-month follow-up, the incision scars were evaluated using the Vancouver scar scale (VSS) and visual analog scale (VAS). Antera 3D camera was used for objective evaluation. Results The VSS score and VAS score were significantly different between the SVF-gel-treated side (3.80 ± 1.37, 3.37±1.25) and the control side (5.25 ± 1.18, 4.94 ± 1.28). Moreover, the SVF-gel-treated side showed statistically significant improvements in scar appearance, based on evidences from Antera 3D camera. Limitations This was a single-center, single-race, and single-gender study. Furthermore, the results were available only for the 6-month interim follow-up period. Conclusion Postoperative immediate SVF-gel injection in surgical incisions can reduce scar formation, and exert a preventive effect

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
AdultFemaleHumansMiddle AgedCicatrixDouble-Blind MethodEstheticsFollow-Up StudiesGelsInjections, Intradermal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research